Panacea Biotec Ltd (PANACEABIO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Panacea Biotec Ltd (PANACEABIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10148
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Panacea Biotec Ltd (Panacea) is a research-based health management company which focuses on manufactures and commercializes pharmaceuticals; biopharmaceuticals; natural, and indigenous products; and vaccines. Its vaccines portfolio includes paediatric vaccines, including trivalent and monovalent oral polio vaccine, and Enivac HB vaccine; and combinative vaccines, including Easyfive-TT (DTwP-HepB-Hib), Novohib (haemophilus typeb conjugate vaccine IP) and Polprotec (inactivated poliomyelitis vaccine). Its pharmaceutical formulations span the therapeutic areas of oncology, nephrology, pain management, diabetes management, and organ transplantation. The company also offers contract research and manufacturing services. Panacea operates research and development centers and manufacturing facilities. It has subsidiaries in India, Switzerland and Germany. Panacea is headquartered in New Delhi, India.

Panacea Biotec Ltd (PANACEABIO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Panacea Biotec Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Panacea Biotec Enters into Agreement with Natco Pharma and Breckenridge Pharma 11
Panacea Biotec Enters into Agreement with Serum Institute of India 12
Panacea Biotech Enters into Agreement with Bionpharma 13
Panacea Biotec Enters into Agreement with Pharma Company for Immunosuppressant Generic Product 14
Panacea Biotec Enters into Agreement with Rising Pharma 15
Panacea Biotec Enters Into R&D Agreement With Kremers Urban For Generic Drugs 16
Osmotica Pharma Enters Into R&D Agreement With Panacea Biotec For Brand And Generic Products 17
Licensing Agreements 18
Bionpharma Enters into Licensing Agreement with Panacea Biotech 18
Panacea Biotec Expands Licensing Agreement with Apotex 19
Equity Offering 20
Panacea Biotec Receives Board Approval for Public Offering of Shares to Raise USD41.5 Million 20
Acquisition 21
Panacea Biotec Plans to Sell Its Stake in NewRise Healthcare 21
Panacea Biotec Ltd – Key Competitors 22
Panacea Biotec Ltd – Key Employees 23
Panacea Biotec Ltd – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 25
Recent Developments 26
Legal and Regulatory 26
Mar 09, 2018: Panacea Biotec Announces Receipt of Establishment Inspection Report (EIR) from USFDA 26
Oct 17, 2017: Panacea Biotec receives Certificate of GMP Compliance with manufacturing authorizations for 22 medicinal products from State Service of Ukraine on Medicines and Drugs Control 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Panacea Biotec Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Panacea Biotec Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Panacea Biotec Enters into Agreement with Natco Pharma and Breckenridge Pharma 11
Panacea Biotec Enters into Agreement with Serum Institute of India 12
Panacea Biotech Enters into Agreement with Bionpharma 13
Panacea Biotec Enters into Agreement with Pharma Company for Immunosuppressant Generic Product 14
Panacea Biotec Enters into Agreement with Rising Pharma 15
Panacea Biotec Enters Into R&D Agreement With Kremers Urban For Generic Drugs 16
Osmotica Pharma Enters Into R&D Agreement With Panacea Biotec For Brand And Generic Products 17
Bionpharma Enters into Licensing Agreement with Panacea Biotech 18
Panacea Biotec Expands Licensing Agreement with Apotex 19
Panacea Biotec Receives Board Approval for Public Offering of Shares to Raise USD41.5 Million 20
Panacea Biotec Plans to Sell Its Stake in NewRise Healthcare 21
Panacea Biotec Ltd, Key Competitors 22
Panacea Biotec Ltd, Key Employees 23
Panacea Biotec Ltd, Other Locations 24
Panacea Biotec Ltd, Subsidiaries 24
Panacea Biotec Ltd, Joint Venture 25

List of Figures
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Panacea Biotec Ltd (PANACEABIO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hanmi Pharmaceuticals Co Ltd (128940):製薬・医療:M&Aディール及び事業提携情報
    Summary Hanmi Pharmaceuticals Co Ltd (Hanmi Pharma), a subsidiary of Hanmi Science Co Ltd is a developer of prescription drugs and over the counter drugs. The company’s prescription drugs include osteoporosis, antibiotics, antidiarrheal, liver supplements and antiemetics. It provides over the counte …
  • Hensel Phelps Construction Co.:企業の戦略・SWOT・財務情報
    Hensel Phelps Construction Co. - Strategy, SWOT and Corporate Finance Report Summary Hensel Phelps Construction Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • KDDI Corporation:企業のM&A・事業提携・投資動向
    KDDI Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KDDI Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Guangshen Railway Company Limited:企業の戦略・SWOT・財務情報
    Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report Summary Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Inovio Pharmaceuticals Inc (INO):医療機器:M&Aディール及び事業提携情報
    Summary Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA immunotherapies and vaccines for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology …
  • Daniel Thwaites Plc:戦略・SWOT・企業財務分析
    Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report Summary Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • First American Financial Corp:企業の戦略・SWOT・財務情報
    First American Financial Corp - Strategy, SWOT and Corporate Finance Report Summary First American Financial Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Investimentos, Participacoes e Gestao SA (INA):企業の財務・戦略的SWOT分析
    Investimentos, Participacoes e Gestao SA (INA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Independence Group NL:企業のM&A・事業提携・投資動向
    Independence Group NL - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Independence Group NL Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Tandem Diabetes Care Inc (TNDM):医療機器:M&Aディール及び事業提携情報
    Summary Tandem Diabetes Care Inc (Tandem) is a medical device company that designs, develops and manufactures diabetic care products. The company provides products such as t:slim X2 insulin pump, t:slim G4 insulin pump, t:flex insulin pump, t:simulator demo app, software and apps, t:connect applicat …
  • Ford Motor Company:企業の戦略・SWOT・財務情報
    Ford Motor Company - Strategy, SWOT and Corporate Finance Report Summary Ford Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • TOTAL S.A.:戦略・SWOT・企業財務分析
    TOTAL S.A. - Strategy, SWOT and Corporate Finance Report Summary TOTAL S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Dover Corporation:企業の戦略・SWOT・財務分析
    Dover Corporation - Strategy, SWOT and Corporate Finance Report Summary Dover Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Amedica Corp (AMDA):製品パイプライン分析
    Summary Amedica Corp (Amedica) is a biomaterial company. It develops, manufactures and markets medical-grade silicon nitride ceramics for spinal and arthroplasty applications. The company offers interbody fusion devices, pedicle screw systems, facet fixation systems and others. Amedica also offers n …
  • Lenenergo (LSNG):企業の財務・戦略的SWOT分析
    Lenenergo (LSNG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Blueprint Medicines Corp (BPMC):医療機器:M&Aディール及び事業提携情報
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, is a drug discovery company that develops drugs for the treatment of cancers and rare diseases. The company discovers and develops selective kinase inhibitors for genomically defined cancer subsets. Its pipel …
  • Fremont Petroleum Corp Ltd (FPL):企業の財務・戦略的SWOT分析
    Fremont Petroleum Corp Ltd (FPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • PCM Inc:企業の戦略・SWOT・財務情報
    PCM Inc - Strategy, SWOT and Corporate Finance Report Summary PCM Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Nabors Industries Ltd.:企業の戦略・SWOT・財務分析
    Nabors Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nabors Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • NV Nuon Energy:発電所・企業SWOT分析
    NV Nuon Energy - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆